Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 3Neutropenia 1Myelodysplastic Syndromes 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cytarabine 25Etoposide 14tipifarnib 10Daunorubicin 10Mitoxantrone 9Idarubicin 7Azacitidine 6alvocidib 5Peripheral Blood Stem Cell Transplantation 5Filgrastim 5Busulfan 5valspodar 4Vorinostat 4fludarabine phosphate 3aldesleukin 3Tretinoin 3Sorafenib 3Radiotherapy 3Gemtuzumab 3Cyclophosphamide 3Bortezomib 3tanespimycin 2sargramostim 2lintuzumab 2laromustine 2entinostat 2Watchful Waiting 2Topotecan 2Thioguanine 2Observation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Leukemia, Megakaryoblastic, Acute × Amsacrine × Clear all
NCT00002658 2013-12-19

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
2,000 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡